BLLN Company Profile and Key Details

NASDAQ : BLLN

BillionToOne

$92.41

1.8+1.99%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

BillionToOne, Inc. (BLLN) stock surged +1.99%, trading at $92.41 on NASDAQ, up from the previous close of $90.61. The stock opened at $91.36, fluctuating between $87.33 and $93.31 in the recent session.

Stock Snapshot

90.61

Prev. Close

4.23B

Market Cap

87.3301

Day Low

-369.64

P/E Ratio

-0.25

EPS (TTM)

N/A

Cash Flow per Share

91.36

Open

45.77M

Number of Shares

93.31

Day High

N/A

Free Float in %

N/A

Book Value

182.69K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 09, 2026	91.36	93.00	87.33	92.41	182.71K
Feb 06, 2026	85.50	91.01	84.14	90.61	100.82K
Feb 05, 2026	83.51	88.36	83.19	85.15	206.51K
Feb 04, 2026	82.26	85.52	82.25	83.51	154.81K
Feb 03, 2026	83.21	85.35	82.25	82.69	182.61K
Feb 02, 2026	82.68	85.53	82.25	83.56	122.71K
Jan 30, 2026	81.18	87.54	81.18	82.51	220.22K
Jan 29, 2026	85.66	86.72	80.65	81.21	257.44K
Jan 28, 2026	86.00	87.80	83.17	86.05	133.71K
Jan 27, 2026	86.58	90.87	85.32	85.56	105.36K
Jan 26, 2026	88.36	94.16	86.12	86.18	169.59K
Jan 23, 2026	91.00	92.77	87.00	87.57	141.21K
Jan 22, 2026	84.68	92.19	84.11	90.56	154.03K
Jan 21, 2026	84.14	86.50	80.00	84.11	283.63K
Jan 20, 2026	85.91	88.04	82.00	85.95	319.28K
Jan 16, 2026	95.00	95.35	85.53	88.73	611.28K
Jan 15, 2026	94.81	96.84	92.44	94.72	302.68K
Jan 14, 2026	99.85	99.85	90.00	94.37	340.98K
Jan 13, 2026	99.85	100.25	95.50	96.85	173.86K
Jan 12, 2026	87.13	101.98	86.64	99.15	277.48K

Contact Details

Menlo Park, CA 94025

United States

https://www.billiontoone.com 650 460 2551

About Company

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a test that provides longitudinal determination of cancer burden through methylation assessment. The company was incorporated in 2016 and is headquartered in Menlo Park, California.

Stock Peers

IDXX

-4.82-0.75%

IDEXX Laboratories, Inc.$639.79 MEDP

-11.69-2.16%

Medpace Holdings, Inc.$530.35 NTRA

7.54+3.71%

Natera, Inc.$210.58 ICLR

3.98+2.64%

ICON Public Limited Company$154.57 ILMN

-2.47-2.06%

Illumina, Inc.$117.25 GH

3.49+3.43%

Guardant Health, Inc.$105.34 EXAS

0.14+0.14%

Exact Sciences Corporation$103.32 GRAL

0.33+0.33%

GRAIL, Inc.$100.40 RDNT

-0.09-0.13%

RadNet, Inc.$69.15 TWST

-1.77-3.59%

Twist Bioscience Corporation$47.47

Company Overview

BillionToOne, Inc. (NASDAQ:BLLN) closed at $92.41 USD, gaining $1.80 (1.99%) from the previous close of $90.61. The stock is currently mid-range between its 52-week high and low $80.00 and $138.70. With a market capitalization of about $4.23 billion, BillionToOne, Inc. is classified as a mid-cap and shows lower-than-market volatility (beta ~0.00). Key stats such as the average daily volume over the past year has been around 210.55 thousand shares, in line with its 52-week average. Headquartered in Menlo Park, CA, BillionToOne, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Oguzhan Atay, the company employs approximately 620 people and listed since November 06, 2025. BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 4.92%, SMA50 -2.0%, SMA200 -3.94%). The stock’s 14-day RSI is 54.62 (neutral), while the ATR of 6.37 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -33.37% below its high and over 15.51% above its low. Average 10-day trading volume of 167.20 thousand shares is below the 3-month average of 206.59 thousand, indicating normal recent market interest.

Valuation Metrics

BillionToOne, Inc. trades at a P/E ratio of -289.15, slightly below the S&P 500 average, with a price-to-sales ratio of 16.54 and a price-to-book ratio of 22.83 reflecting a rich premium to book value. The P/FCF stands at -1033.03, also below market averages. Compared to sector medians, BillionToOne, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Earnings & Analyst Outlook

Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 3 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $160.00 to $110.00. The high target offers 73.14% upside. The low target suggests 19.03% downside. The mean target is $142.75. This offers 54.47% upside. BillionToOne, Inc. earnings surprise history is a mixed track record. The quarter that ended December 09, 2025, missed forecasts by -37.5%.

Financial & Profitability Overview

Over the trailing twelve months, BillionToOne has not generated any revenue.
On valuation metrics, BillionToOne trades at a P/E of -289.15, P/S of 16.54 and P/B of 22.83. The current ratio is 6.17 and quick ratio is 5.75. Operationally, the company’s inventory turnover is 5.09 and cash conversion cycle is 89.25 days. Debt-to-equity is 0.60, supported by a cash flow-to-debt ratio of 0.05.

Price Forecast & Outlook

Our AI price prediction model suggests that BillionToOne, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -3.0%, with price expected at $89.64 by February 23, 2026, within a range of $84.05 to $95.21 3-Month Outlook: Projected fall of -99.44%, reaching $0.52 by May 07, 2026, with a range of $0.00 to $1.23. 1-Year Outlook: Projected gain of 549.39%, with price at $600.10 by February 09, 2027, within a range of $598.68 to $601.42.

Key Takeaways

BillionToOne, Inc. (NASDAQ:BLLN) shares are flat 5.02% year-to-date currently trading near 52-week highs band. Valuation shows BillionToOne, Inc. trading at a premium to the broader market with a P/E of -289.15. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $142.75, suggesting 54.47% upside. Our AI forecast model points to short-term weakness (-3.0% over two weeks), a medium-term fall (-99.44% over three months), and a longer-term gain (549.39% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current BillionToOne, Inc. (BLLN) stock price?

BillionToOne, Inc. (NASDAQ: BLLN) stock price is $92.41 in the last trading session. During the trading session, BLLN stock reached the peak price of $93.31 while $87.33 was the lowest point it dropped to. The percentage change in BLLN stock occurred in the recent session was 1.99% while the dollar amount for the price change in BLLN stock was $1.80.

BLLN's industry and sector of operation?

The NASDAQ listed BLLN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. BillionToOne, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of BLLN?

No Data

How BLLN did perform over past 52-week?

BLLN's closing price is 15.51% higher than its 52-week low of $80.00 where as its distance from 52-week high of $138.70 is -33.37%.

How many employees does BLLN have?

Number of BLLN employees currently stands at 620.

Link for BLLN official website?

Official Website of BLLN is: https://www.billiontoone.com

How do I contact BLLN?

BLLN could be contacted at phone 650 460 2551 and can also be accessed through its website. BLLN operates from 1035 O’Brien Drive, Menlo Park, CA 94025, United States.

How many shares of BLLN are traded daily?

BLLN stock volume for the day was 182.69K shares. The average number of BLLN shares traded daily for last 3 months was 210.55K.

What is the market cap of BLLN currently?

The market value of BLLN currently stands at $4.23B with its latest stock price at $92.41 and 45.77M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	620
Beta	0
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Medical - Diagnostics & Research

BLLN Company Profile and Key Details

BillionToOne

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Price Forecast & Outlook

Valuation Metrics

Key Takeaways